Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chiron

Showing results (861-870 of 892) with videos related to

Pageof 90
Sort By:
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|June 28, 2020
Clinical response to lumacaftor-ivacaftor in patients with cystic fibrosis according to baseline lung functionPierre-Régis Burgel, Isabelle Durieu, Raphaël Chiron, et al.
Proceedings of Machine Learning Research|July 12, 2024
Alleviating tiling effect by random walk sliding window in high-resolution histological whole slide image synthesisShunxing Bao, Ho Hin Lee, Qi Yang, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|May 27, 2025
Cannabinoid receptor 2 agonist, lenabasum, for the treatment of pulmonary exacerbations in cystic fibrosisNatalie E West, Michael W Konstan, Patrick A Flume, et al.
Journal for Immunotherapy of Cancer|January 21, 2022
Targeting CD38 and PD-1 with isatuximab plus cemiplimab in patients with advanced solid malignancies: results from a phase I/II open-label, multicenter studyPaolo Andrea Zucali, Chia-Chi Lin, Bradley C Carthon, et al.
The Lancet. Respiratory Medicine|September 6, 2025
Sweat chloride and lung function responses to elexacaftor-tezacaftor-ivacaftor in people with cystic fibrosis with two versus one responsive CFTR variants: an analysis of two real-world observational studiesPierre-Régis Burgel, Jennifer Da Silva, Emmanuelle Girodon, et al.
Neurology|June 25, 2003
Spectrum of SCN1A mutations in severe myoclonic epilepsy of infancyR Nabbout, E Gennaro, B Dalla Bernardina, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 11, 2010
Disentangling the role of environmental and human pressures on biological invasions across EuropePetr Pysek, Vojtech Jarosík, Philip E Hulme, et al.
Orphanet Journal of Rare Diseases|September 10, 2020
Childhood Langerhans cell histiocytosis with severe lung involvement: a nationwide cohort studySolenne Le Louet, Mohamed-Aziz Barkaoui, Jean Miron, et al.
BMJ Open|July 28, 2022
Impact of a phone call with a medical student/general practitioner team on morbidity of chronic patients during the first French COVID-19 lockdown (COVIQuest): a cluster randomised trialClarisse Dibao-Dina, Julie Léger, Isabelle Ettori-Ajasse, et al.
Cell Reports. Medicine|February 19, 2026
Targeting BCMA in multiple myeloma with a trifunctional NK cell engagerAlexandre Tang, Laurent Gauthier, Elisa Zaghi, et al.
Pageof 90

Showing results (861-870 of 892) with videos related to

Sort By:
Pageof 90
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|June 28, 2020
Clinical response to lumacaftor-ivacaftor in patients with cystic fibrosis according to baseline lung functionPierre-Régis Burgel, Isabelle Durieu, Raphaël Chiron, et al.
Proceedings of Machine Learning Research|July 12, 2024
Alleviating tiling effect by random walk sliding window in high-resolution histological whole slide image synthesisShunxing Bao, Ho Hin Lee, Qi Yang, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|May 27, 2025
Cannabinoid receptor 2 agonist, lenabasum, for the treatment of pulmonary exacerbations in cystic fibrosisNatalie E West, Michael W Konstan, Patrick A Flume, et al.
Journal for Immunotherapy of Cancer|January 21, 2022
Targeting CD38 and PD-1 with isatuximab plus cemiplimab in patients with advanced solid malignancies: results from a phase I/II open-label, multicenter studyPaolo Andrea Zucali, Chia-Chi Lin, Bradley C Carthon, et al.
The Lancet. Respiratory Medicine|September 6, 2025
Sweat chloride and lung function responses to elexacaftor-tezacaftor-ivacaftor in people with cystic fibrosis with two versus one responsive CFTR variants: an analysis of two real-world observational studiesPierre-Régis Burgel, Jennifer Da Silva, Emmanuelle Girodon, et al.
Neurology|June 25, 2003
Spectrum of SCN1A mutations in severe myoclonic epilepsy of infancyR Nabbout, E Gennaro, B Dalla Bernardina, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 11, 2010
Disentangling the role of environmental and human pressures on biological invasions across EuropePetr Pysek, Vojtech Jarosík, Philip E Hulme, et al.
Orphanet Journal of Rare Diseases|September 10, 2020
Childhood Langerhans cell histiocytosis with severe lung involvement: a nationwide cohort studySolenne Le Louet, Mohamed-Aziz Barkaoui, Jean Miron, et al.
BMJ Open|July 28, 2022
Impact of a phone call with a medical student/general practitioner team on morbidity of chronic patients during the first French COVID-19 lockdown (COVIQuest): a cluster randomised trialClarisse Dibao-Dina, Julie Léger, Isabelle Ettori-Ajasse, et al.
Cell Reports. Medicine|February 19, 2026
Targeting BCMA in multiple myeloma with a trifunctional NK cell engagerAlexandre Tang, Laurent Gauthier, Elisa Zaghi, et al.
Pageof 90